CSL Seqirus, a business of CSL (ASX: CSL), today announced data from a range of real-world evidence (RWE) studies, highlighting the important role influenza vaccination plays in protecting public ...

We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks ...

CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT ...

Research, development, manufacture, marketing and distribution of biopharmaceutical products and vaccines.

Head-to-head data, presented at OPTIONS XII for the Control of Influenza Conference, demonstrates advantage of sa-mRNA over conventional mRNA in duration of immune response; Results highlight CSL ...

Tech unicorn Atlassian reported $200 million in research and development expenditure in 2021-2022, topping the inaugural ATO ...

At CSL Group, Glenn will lead the company's technology strategy and development, focusing on enhancing its portfolio of multi sector secure connectivity solutions. His appointment underscores CSL ...

With the ASX at all time highs, Wilson Asset Management's Matthew Haupt shares where he is finding value right now.

The top-of-the-line BMW M4 CS gets an improved chassis and is powered by a 3.0-litre twin-turbo straight-six engine tuned to ...

Here's why these buy-rated ASX stock picks could be great long term options for investors. Here's what you need to ...